|
Preventing Depression in Patients with Macular Degeneration Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on Preventing Depression in Patients with Macular Degeneration conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Preventing Depression in Patients with Macular Degeneration Clinical research trials and Preventing Depression in Patients with Macular Degeneration healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including Preventing Depression in Patients with Macular Degeneration. Preventing Depression in Patients with Macular Degeneration Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a Preventing Depression in Patients with Macular Degeneration clinical trial. Participants typically obtain the most effective healthcare available for their Preventing Depression in Patients with Macular Degeneration condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "P" Clinical Trials Conditions > Preventing Depression in Patients with Macular Degeneration  Preventing Depression in Patients with Macular Degeneration
Preventing Depression in Patients with Macular Degeneration
For Condition: Depression,Macular Degeneration
Status: Recruiting
Sponsor(s): National Institute of Mental Health (NIMH) ,
Synopsis: The purpose of this study is to evaluate the efficacy of a brief, standardized cognitive psychotherapy called Problem Solving Treatment (PST) to prevent depression in elderly patients with age-related macular degeneration (AMD).
Details: AMD is the most common cause of blindness in older adults. The disease limits the ability to read, see familiar faces, and walk independently. Almost 2 million persons (about 5 percent of the U.S. population over age 65) are now affected, and this number will triple by the year 2020. This study will target patients with neovascular AMD (NV-AMD), a form of AMD which can lead to sudden vision loss, substantial disability, and depression. Because depression is itself disabling and not likely to be recognized nor treated by ophthalmologists, preventing depression in people with NV-AMD is important. Patients are randomly assigned to either PST or a usual care control condition. The primary outcome measure is a DSM-IV diagnosis of depression. Patients are evaluated at baseline, Month 2 (immediately post-intervention), Month 6 (for the primary efficacy analysis), and Month 12 (to evaluate sustained effects). The study will also assess the impact of PST on levels of disability and vision-related quality of life.
Eligibility:
Study Type: Interventional, Prevention, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study
Minimum Age/Maximum Age: 65 Years/
Genders: Both
Protocol Entry Criteria: Inclusion criteria: - Bilateral macular degeneration - Visual acuity of 20/40 or worse in better eye - Residence within 40 miles of Wills Eye Hospital in Philadelphia, PA
Total Enrollment: 230
Location and Contact Information:
Jefferson Medical College and Wills Eye Hospital *Recruiting*
Philadelphia, Pennsylvania, 19107
United States
Recruiting Robin Casten 215-503-1250
Additional Information:
Study ID Numbers: 61331-01A1;
Study Start Date: February 2001
Record last reviewed: January 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00042211
Other Depression Studies:
1. Genetic Factors in Age-Related Macular Degeneration
2. Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders
3. Randomized Trials of Vitamin Supplements and Eye Disease
4. Complications of Age-Related Macular Degeneration Prevention Trial (CAPT)
5. Fluocinolone Implant to Treat Macular Degeneration
Related Studies:
Other Depression Clinical Trials
Other Pennsylvania Clinical Trials
Other Philadelphia Clinical Trials
Preventing Depression in Patients with Macular Degeneration
|
|
|
|
|
|
|
|
